The natural and the social world shaped the evolution of each. Knowing whom to invite to dinner is as important as knowing ...

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

But here's why you likely won't be seeing it in your doctor's office anytime soon.

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. That’s according to new research from the University of California San Diego, which found that a ...

Women are twice as likely to be affected by dementia ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. That’s according to new research from the University of California San Diego, which found that a ...

As AI systems began acing traditional tests, researchers realized those benchmarks were no longer tough enough. In response, nearly 1,000 experts created Humanity’s Last Exam, a massive 2,500-question ...

There’s a particular kind of sleep that usually requires a hotel reservation. The comforter is impossibly light. The room is ...

The California governor didn't hold back after the president called him a "cognitive mess" and accused him of being racist.

Researchers from the University of California San Diego have found that a novel blood-based biomarker can predict a woman's risk of developing dementia as many as 25 years before symptoms appear.

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...